These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10514113)

  • 1. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection.
    Goh J; Coughlan B; Quinn J; O'Keane JC; Crowe J
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):833-8. PubMed ID: 10514113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection.
    Barrett S; Goh J; Coughlan B; Ryan E; Stewart S; Cockram A; O'Keane JC; Crowe J
    Gut; 2001 Sep; 49(3):423-30. PubMed ID: 11511566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
    Lee YS; Yoon SK; Chung ES; Bae SH; Choi JY; Han JY; Chung KW; Sun HS; Kim BS; Kim BK
    J Korean Med Sci; 2001 Oct; 16(5):585-91. PubMed ID: 11641527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection.
    Kallman J; O'Neil MM; Larive B; Boparai N; Calabrese L; Younossi ZM
    Dig Dis Sci; 2007 Oct; 52(10):2531-9. PubMed ID: 17406828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
    Kirdar S; Sener AG; Cengİz M; Aydin N
    APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Rosario P; Mormone G; Ragone E; Pasquale G; Ruggiero G
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):299-304. PubMed ID: 10750650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance.
    Fukuda R; Ishimura N; Niigaki M; Hamamoto S; Satoh S; Tanaka S; Kushiyama Y; Uchida Y; Ihihara S; Akagi S; Watanabe M; Kinoshita Y
    J Med Virol; 1999 Jul; 58(3):201-7. PubMed ID: 10447413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C.
    Malaguarnera M; Guccione N; Musumeci S; Brogna A; Motta M; Di Fazio I
    BioDrugs; 2004; 18(1):63-70. PubMed ID: 14733608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
    Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
    Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease.
    Sagnelli E; Coppola N; Scolastico C; Mogavero AR; Filippini P; Piccinino F
    J Med Virol; 2001 Jul; 64(3):350-5. PubMed ID: 11424125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
    Adinolfi LE; Utili R; Andreana A; Tripodi MF; Marracino M; Gambardella M; Giordano M; Ruggiero G
    Dig Dis Sci; 2001 Aug; 46(8):1677-83. PubMed ID: 11508667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.
    Fanning L; Kenny E; Sheehan M; Cannon B; Whelton M; O'Connell J; Collins JK; Shanahan F
    Hepatology; 1999 Mar; 29(3):904-7. PubMed ID: 10051496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management.
    Gupta RK; Sakhuja P; Majumdar K; Ali S; Srivastava S; Sachdeva S; Sharma BC; Puri AS
    Indian J Pathol Microbiol; 2018; 61(3):345-349. PubMed ID: 30004052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus transmission in family members of Egyptian patients with HCV related chronic liver disease.
    Madwar MA; El-Gindy I; Fahmy HM; Shoeb NM; Massoud BA
    J Egypt Public Health Assoc; 1999; 74(3-4):313-32. PubMed ID: 17219873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.